FFRct vs VX1+
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, HeartFlow FFRct Analysis, is a diagnostic tool that uses AI to create 3D models from CCTA scans for non-invasive assessment of coronary artery disease. Conversely, Tool B, Volta Medical VX1+, is an AI-powered software designed to assist electrophysiologists in real-time during cardiac ablation procedures for atrial fibrillation and tachycardia by identifying abnormal electrograms. While both are cardiology AI solutions, they address different clinical problems and stages of patient care.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
HeartFlow FFRct Analysis is a non-invasive AI-powered diagnostic tool that creates personalized 3D models of coronary arteries to assess blood flow and aid in diagnosing coronary artery disease (CAD). VX1+ is AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation (AF) and atrial tachycardia (AT).
HeartFlow FFRct Analysis is designed for cardiology and radiology specialties, aiding in the diagnosis and treatment planning of coronary artery disease. VX1+ is primarily for cardiology, specifically assisting electrophysiologists during interventional cardiac ablation procedures.
HeartFlow FFRct Analysis is cloud-based, utilizing a local Virtual Appliance for data transfer of CCTA scans for processing. VX1+ is a software application that integrates with existing EP recording and 3D mapping systems, such as the Abbott EnSite X 3D mapping system.
HeartFlow FFRct Analysis utilizes AI and computational fluid dynamics (CFD) to generate personalized 3D digital models of coronary arteries and analyze blood flow. VX1+ employs AI-powered software, including machine and deep learning algorithms, for real-time annotation and identification of spatio-temporal dispersed electrograms (DEs).
HeartFlow FFRct Analysis aids in diagnosing CAD and helps guide treatment strategies and revascularization decisions by providing FFRct values. VX1+ provides AI-driven insights to assist electrophysiologists in real-time during ablation procedures by identifying abnormal electrograms.
HeartFlow FFRct Analysis has a Business Associate Agreement (BAA) and is HIPAA compliant, in addition to being FDA cleared. VX1+ is FDA cleared, and while HIPAA compliance and a BAA are expected for a medical device handling patient data in the U.S., they are not explicitly stated in the provided information.